A UAE-backed biotech company tests an AI-engineered drug

Dr. Alex Zhavoronkov said the progress of AI-driven drug trials represents a milestone.  Photo: Medicina Insilico

A UAE-backed biotech company has begun testing a drug discovered and engineered using artificial intelligence on patients. Insilico Medicine, which is headquartered in Hong Kong and has an R&D center in Abu Dhabi, has leveraged advanced technology to develop a drug for the treatment of idiopathic pulmonary fibrosis, a chronic lung disease that causes lung … Read more

Drug Modeling Software Competitor Analysis Insights Market Trends, Size, Share and Future Growth to 2030 by Applications and Outlook | Crown Bioscience Inc., Chemical Computing Group Ulc

Drug Modeling Software Competitor Analysis Insights Market Trends, Size, Share and Future Growth to 2030 by Applications and Outlook |  Crown Bioscience Inc., Chemical Computing Group Ulc

“Worldwide Market Reports offers a70% discount.drug modeling software market reports on single user access and unlimited user access“ Overview Drug Modeling Software Market Forecast 2023 to 2030the research provides accurate global and national economic forecasts and analysis. It provides a comprehensive competitive market perspective, as well as in-depth supply chain analysis to help companies identify … Read more

First AI-Generated Drug Enters Human Clinical Trials, Targeting Patients With Chronic Lung Diseases

Insilico Medicines CEO Alex Zhavoronkov (left) said the drug would undergo the same tests to ascertain its efficacy and safety.

Technician By Melissa Rudy, Fox News June 29, 2023 | 1:17 The first AI-generated drug has entered Phase 2 clinical trials, with the first dose successfully administered to a human, Insilico Medicine announced yesterday. The drug, currently called INS018_055, is being tested for the treatment of idiopathic pulmonary fibrosis (IPF), a rare and progressive type … Read more